Navigation Links
Researchers unfold the mechanisms underlying blood disorders
Date:7/24/2012

A Finnish research team together with researchers from New York, USA, has uncovered a protein structure that regulates cell signalling and the formation of blood cells. The team's results, published in Nature Structural & Molecular Biology, the most prestigious journal in the field, shed light on the mechanisms at play in haematological disorders and provide new opportunities for the design of disease-specific treatment. The work was carried out with funding from the Academy of Finland, the Cancer Society of Finland, National Institutes of Health and the Sigrid Juslius Foundation.

Blood cell formation and activity is regulated by cytokines, small cell-signalling protein molecules, through a signal pathway mediated by Janus kinases (JAKs), a family of enzymes. Previous studies have shown that mutations in JAKs can cause severe haematological disorders as well as immunological diseases. These mutations are concentrated in the pseudokinase domain.

Leading laboratories and pharmaceutical companies around the world have long aimed at defining the structure of the pseudokinase domain of JAKs, as it has been found to be a veritable hotspot for pathogenic mutations causing haematological disorders. Led by Professor Olli Silvennoinen, the Finnish research team has now successfully determined the three-dimensional atomic-level structure of both the normal and the pathogenic pseudokinase domain.

Novel therapeutics

Professor Silvennoinen's team is the first to describe the structure of the pseudokinase domain of JAKs, laying bare the domain's enzymatic mechanisms at the atomic level. The team also managed to determine the structural change, caused by the JAK2 V617F mutation, which gives rise to common myeloproliferative diseases (MPDs), such as polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF). PV and ET are blood disorders characterised by an overproduction of red blood cells or platelets, whereas MF is a disorder that causes scar tissue to accumulate in the bone marrow. The team's research results can be put to good use in developing new, targeted therapeutics for these disorders.

The study now published in Nature Structural & Molecular Biology builds on the long-standing expertise of Professor Silvennoinen's team in Janus kinases. In the early 1990s, while working in the US, Silvennoinen successfully cloned the JAK2 gene and demonstrated its activity in the signalling pathways of erythropoietin and interferon. In Finland, the Silvennoinen's work focused on the pseudokinase domain, determining and characterising its regulatory function.


'/>"/>
Contact: Professor Olli Silvennoinen
olli.silvennoinen@uta.fi
358-503-595-740
Academy of Finland
Source:Eurekalert

Related medicine news :

1. New lipid screening guidelines for children overly aggressive, UCSF researchers say
2. BUSM researchers identify genetic markers for testosterone, estrogen level regulation
3. UGA researchers develop rapid diagnostic test for pathogens, contaminants
4. Moffitt Cancer Center researchers find potential key to new treatment for mantle cell lymphoma
5. Researchers link Kawasaki Disease in childhood with increased risk of adult heart disease
6. Researchers to use novel metabolomics technology for COPD
7. Researchers hit back at early bodycheck theory
8. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
9. Researchers developing new multiple sclerosis drug that can be taken orally
10. UMass Amherst researchers unravel secrets of parasites replication
11. U-M researchers identify new genetic cause for chronic kidney disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... 20, 2020 , ... TMQuotes , a revolutionary cloud-based ... API integration functionality which enables agents to take more involved ownership over their ... the first white label software-as-a-service (SaaS) to give insurance agents and brokers the ...
(Date:2/19/2020)... MIAMI (PRWEB) , ... February 19, 2020 , ... ... to the film industry. While he is most known for his acting abilities ... exceptional host on the educational show “Behind The Scenes” with Laurence Fishburne. “Behind ...
(Date:2/19/2020)... , ... February 19, 2020 , ... ... implant manufacturer, will highlight its growing product portfolio for lower extremities at the ... the Henry B. Gonzalez Convention Center. The Trigon® Ti Stand-Alone Osteotomy Wedge Fixation ...
(Date:2/16/2020)... , ... February 16, 2020 , ... Canadian digital healthcare ... the world to call who are concerned about the Coronavirus. , "It is our ... are trying to contain this deadly virus" said Prakash Chand, CEO of Ask The ...
(Date:2/14/2020)... ... 2020 , ... ScripHessco has announced the release of their ... down the benefits of chiropractic care during pregnancy and how to find a ... beneficial to the mother’s health. Seeing a chiropractor during pregnancy leads to a ...
Breaking Medicine News(10 mins):
(Date:2/23/2020)... ... , ... The University of Minnesota’s Integrated Food Systems Leadership Program ... ’ in Food Safety Magazine's February/March issue. The publication’s cover story, authored ... the boundaries that food system leaders need to break in order to address grand ...
(Date:2/21/2020)... ... ... The business of healthcare management is complex. From providing the best care to ... and physical safety, there are many things to keep up with. Very often, building ... to provide their insights on healthcare facility maintenance to attendees at the North ...
(Date:2/20/2020)... N.J. (PRWEB) , ... February 20, 2020 , ... ... Scottsdale Resort, 6333 North Scottsdale Road, in Arizona, will be a timely and ... of relevant, practical instruction in the management of chronic pain. , In 2020, ...
Breaking Medicine Technology: